Copyright
©2012 Baishideng Publishing Group Co.
World J Gastroenterol. Jun 7, 2012; 18(21): 2600-2608
Published online Jun 7, 2012. doi: 10.3748/wjg.v18.i21.2600
Published online Jun 7, 2012. doi: 10.3748/wjg.v18.i21.2600
Class | Drugs | FDA category | Pregnancy advice | Detection in breast milk |
Aminosalicylates | Sulfasalazine, balsalazide, mesalazine | B | Safe to use (folate supplementation for sulfasalazine) | Low levels detectable |
Aminosalicylates | Olsalazine | C | Safe to use | |
Antibiotics | Metronidazole | B | Safe to use | |
Antibiotics | Ciprofloxacin | Limited data; probably safe | ||
Corticosteroids | Prednisolone, budesonide | C | Safe to use | Detectable |
Thiopurines | Azathioprine, 6-mercaptopurine | D | Safe to use | Very low levels detectable |
Folate antagonist | Methotrexate | X | Absolutely contraindicated | |
Biological agent | Infliximab | B | Probably safe (avoid during 3rd trimester) | Not detectable |
Biological agent | Adalimumab | B | Probably safe (avoid during 3rd trimester) | Very low levels detectable |
- Citation: Selinger CP, Leong RW, Lal S. Pregnancy related issues in inflammatory bowel disease: Evidence base and patients' perspective. World J Gastroenterol 2012; 18(21): 2600-2608
- URL: https://www.wjgnet.com/1007-9327/full/v18/i21/2600.htm
- DOI: https://dx.doi.org/10.3748/wjg.v18.i21.2600